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The Philosophical and Evidentiary Basis of Homoeopathic Immunisation: a Response to 
Teixeira 
 
 
Introduction 
 
Homoeopathic immunisation (homoeoprophylaxis – HP) is controversial even within the 
homoeopathic community. Teixeira, whilst writing to support the use of genus epidemicus 
(GE) remedies in the prevention of epidemic diseases, has attacked the prophylactic use of 
nosodes claiming that they “do not take the epistemological features of Hahnemann's 
homoeopathy into account nor exhibit scientific evidence”. He has further suggested that 
advocates of this approach, such as Dr Dorothy Shepherd and this author, “transgress the 
bioethical principles of beneficence and non-maleficence”1. 
 
However Teixeira has failed to fully understand the Principal of Similars, he has used a 
double standard when comparing evidence using GE remedies and nosodes, he has misread 
information demonstrating the safety of long-term HP, and he appears to be unaware of 
scientific evidence which is available supporting the prophylactic use of nosodes. 
 
The Principal of Similars 
 
Teixeira correctly stated that when applied to homoeopathic treatment the Principal of 
Similars directs that “substances causing symptoms on healthy individuals can be used to 
heal similar symptoms in sick individuals”(p.157).  
 
However when applied to homeopathic prevention, the Principle of Similars can be restated 
in two ways: 
(1) A substance which can cure symptoms of an infectious disease is capable of preventing 
similar symptoms in previously unprotected people. Hahnemann's use of Belladonna to both 
cure and prevent scarlet fever is an example of this statement. 
(2) A substance which can cause symptoms similar to the common symptoms of an infectious 
disease is capable of preventing similar symptoms in previously unprotected people. 
Hahnemann’s proving of China is an example of this statement, as is the use of appropriately 
selected nosodes. 
 
It is correct that if different outbreaks of the same disease produce dissimilar symptoms, then 
a single remedy will not provide effective prophylaxis in both outbreaks. However if the 
common symptoms of the different outbreaks are similar, then a remedy chosen because of 
its similarity to these common symptoms (whether a GE remedy or a nosode) will be 
effective in both. This statement holds true even though different people acquiring the disease 
may need different remedies for treatment. This is the very reason why Kent stated that 
prophylaxis is easier than treatment.  
 
Teixeira incorrectly interprets Hahnemann’s attack in Aphorism 56 on the use of Isopathy – 
“a method of curing a given disease by the same contagious principle that produces it” 
(p.161) – as an attack on the use of nosodes in disease prevention. Firstly, it is highly unlikely 
that the organism used to prepare a nosode of say pertussis would be identical with the strain 
of the organism against which it is being used as preventative. It certainly would not use 
material from the same patient as in true Isopathy where, for example, a patient’s own blood 
or urine is potentised and prescribed to the patient as a remedy. Thus, we are not using ”the 
same”. Secondly, Hahnemann was referring to treatment of established diseases, not the 
prevention of a disease. Thirdly, Hahnemann elsewhere stated that once a substance is 
potentised it is no longer identical – “even if the prepared itch substance should be given to 
the same patient from whom it was taken, it would not remain idem (the same), as it could 
only be useful to him in a potentized state, since crude itch substance which he has already in 
his body as an idem is without effect on him. But the dynamization or potentizing changes it 
and modifies it; …Thus potentized and modified also, the itch substance (Psorin) when taken 
is no more an idem (same) with the crude original itch substance, but only a simillimum 
(thing most similar)”2. So Hahnemann expressed a range of views on this issue. 
 
Teixeira incorrectly stated that nosodes could not be used homoeopathically because they 
have not been subjected to pathogenic trials (provings). In fact some small provings of a 
range of nosodes have been undertaken. However, just as the use of toxicological information 
pertaining to a substance can appropriately be incorporated into the Materia Medica of the 
substance alongside provings, so can knowledge of the common symptoms produced by an 
organism be used in the Materia Medica of that organism3. So, as noted above, it is possible 
to select nosodes for use in an HP program based totally on the Principle of Similars, and in 
fact that is the only basis on which any substance used in an HP program should be selected. 
 
Evidence Supporting the Efficacy of GE Remedies 
 
Teixeira presents a thorough outline of the use of homoeopathy in epidemic diseases. 
However most of the evidence presented relates to the successful use of homeopathy in 
treating resulting cases of disease, not in prevention. There are a few examples given relating 
to prevention using GE remedies, none of which formed part of randomised control trials 
(RCTs). However when Teixeira attacked the use of HP he complained that there was an 
absence of controlled clinical studies. This is a clear double standard as is his criticism of HP 
using nosodes because there is no evidence that antibodies are produced, without applying the 
same test to GE results. In fact, homeopathic immunisation using either approach does not 
rely on antibody stimulation and so testing is not expected to show changed antibody levels. 
 
Teixeira describes some of the relatively few RCTs used to evaluate homoeopathic treatment, 
about which there is considerable disagreement between the homoeopathic and allopathic 
professions. However the use of RCTs is increasingly seen within the allopathic literature to 
be problematical due to fundamental flaws in design which means that the practical relevance 
of findings is frequently compromised4,5,6.  
 
So just as the findings of well-constructed studies using GE remedies should be accepted, so 
should well-constructed studies using nosodes. Examples of such studies will be presented 
below. 
 
Evidence of the Safety of HP Using Nosodes 
 
Teixeira incorrectly states that “Golden report rates of adverse effects higher than 10% in 
children subjected to this method – similar to those of conventional vaccination”(p.165). In 
fact the per-dose reaction rate was 1.5%7 (page 150), which is considerably less than that 
expected per dose from vaccination. 
 
Further, the author conducted a separate study examining the long-term safety of four 
methods of immunisation – vaccination, HP, constitutional protection, and no method at all. 
The results using diagnoses made by GPs are presented in Table 1, which clearly show that 
the use of appropriate long-term HP is significantly less damaging than vaccination, and in 
fact appears to be no less safe than the use of general or constitutional treatment as an 
immunisation option. It showed, for example, that vaccinated children had 15 times greater 
chance of developing asthma than children using an appropriate HP program (based around 
nosodes). 
 
 
Table 1:  The Comparative Long-Term Safety of HP Using GP Diagnoses 
 
                                 Method 
Condition Measurement HP 
only 
Vaccinat- 
ion only 
General 
only 
Nothing 
Asthma Odds Ratio 0.124 1.89 0.49 0.69 
 Chi Test P 0.0006 0.0007 0.13 6.5E-40 
      
Eczema Odds Ratio 0.239 1.76 0.225 0.665 
 Chi Test P 0.0097 0.006 0.025 6.5E-40 
      
Ear/ Odds Ratio 0.703 1.517 0.599 0.401 
Hearing Chi Test P 0.364 0.04 0.282 9.4E-41 
      
Allergies Odds Ratio 0.307 1.518 0.446 0.608 
 Chi Test P 0.038 0.061 0.171 5.8E-40 
      
Behaviour Odds Ratio 0.541 0.784 1.675 0.784 
 Chi Test P 0.055 0.613 0.049 1.2E-40 
 
 
Scientific Evidence of the Effectiveness of HP using Nosodes 
 
There is a growing body of rigorous scientific evidence supporting the effectiveness of 
homoeopathic immunisation whether using GE remedies or nosodes. There are very few if 
any RCTs of value - however, as stated above, this in no way limits the value of the findings 
from well-constructed studies. These studies cover both short-term and long-term uses. 
 
Short-term: one of the best reports (in English) of the use of nosodes for short-term 
protection was during an outbreak of meningococcal meningitis type B in Brazil in 1998. The 
Doctors conducting the intervention in 65,826 children followed this group plus another group 
of 23,539 unimmunisednchildren for 12 months. They reported the effectives of the 
intervention at 95% after 6 months and 91% after 12 months. 
 
Long-term: the research conducted by the author from 1986 to 2004 using long-term HP, 
and using mainly nosodes and one GE remedy, yielded the following results surveying 2,342 
child years:     
Effectiveness = 90.4%  -  CI = 87.6% - 93.2% (P=0.05). 
The study was not controlled. However it is possible to use a de facto control via National 
Attack Rates for the three diseases for which there were failures. Table 2 shows these figures. 
 
Table 2: A Comparison of National and HP Attack Rates 
 
Disease Attack Rate, 
Unimmunised  
% 
Attack Rate,  
HP 
% 
Efficacy of HP  
% 
Whooping Cough 85.0 11.7 86.2 
Measles 90.0 9.0 90.0 
Mumps 
 
70.0 5.9 91.6 
 
It is appropriate to acknowledge the significant contribution made to HP evidence by the 
scientists at the Finlay Institute in Havana Cuba. They undertook interventions in 2007 and 
2008 in over 2.2 million people against increasing levels of leptospirosis triggered by severe 
hurricane damage. The interventions were highly successful, and led to the homoeopathic 
immunisation (based around nosodes) of the entire country over 12 months of age against 
swine flu in 2009/10, over 9.8 million people. HP is also being used against pneumococcal 
disease, hepatitis A and Dengue Fever. The Cubans generally use a combination of nosodes 
and GE remedies. Whilst this is not the approach used by the author, the Cuban approach 
does work almost certainly because every remedy in the mixture has a degree of similarity to 
the common symptoms of the infectious disease it is targeted to prevent. 
 
Table 3 provides a snapshot of the use of HP, both GE remedies and nosodes, from 
Hahnemann’s time till today. Where quantified, measures of effectiveness were shown to be 
comparably effective to results using vaccines in real world situations. 
 
Table 3: A Snapshot of the Historical Use of HP 
 
Year Author(s) Disease Type Numbers Effectiveness 
1798 Hahnemann8 Scarlet Fever GE   
1801 Dudgeon9 Scarlet Fever GE 1,646 92.9% 
1831 Hahnemann10 Cholera GE   
1831 Hufeland11 Scarlet Fever GE   
1849 Von 
Boenninghausen12 
Cholera GE   
1884 Burnett13 Smallpox Nosode   
1900 Kent14 Various GE   
1907 Eaton15 Smallpox Nosode 2,806 97.5% 
1920 Close16 Various GE   
1932 Chavanon17 Diphtheria Nosode   
1941 Patterson and Boyd18 Diphtheria Nosode 33  
1950 Taylor Smith19 Polio GE 82 No cases reported 
1956 Heisfelder20 Polio GE 6,000 No cases reported 
1963 Gutman21 Influenza Nosode 385 86.0% 
1967 Shepherd22 Various Nosode/GE   
1968 Krishnamurty23 Influenza Nosode   
1972 Sankaran P24 Various Nosode/GE   
1974 Castro & Noguiera25 Meningitis Nosode 18,640/6,340 86.1% 
1976 Blackie26 Influenza Nosode   
1976 Mathur27 Various Nosode/GE   
1982 Speight28 Various Nosode/GE   
1989 Lockie29 Various Nosode/GE   
1991 Eizayaga30 Various Nosode   
1991 Sethi31 Diphth; Measles; 
Polio; Pertussis 
Nosode/GE   
1993 Lessell32 Various Nosode/GE   
1996 CCRH33 Dengue Fever Nosode 23,250 99.8% 
1998 Mroninski34 Meningitis type B Nosode 65,826/23,539 92.4% – 91.0% 
1999 Srinivasulu35 Japanese 
Encephalitis 
GE 20million Cases reduced to 0 after 
3 years 
2001 Marino36 Dengue Fever GE   
2003 Partington37 Malaria Nosode 33  
2004 Golden38 Pertussis; 
Measles; Mumps 
Nosode 2,342 child 
years 
 Pertussis=86.2%; Mumps  
 = 91.6%;  Measles=90.0% 
2006 Minah & Margai39 Malaria Nosode 731  
2007 Nunes40 Dengue Fever GE 156,129 Significant fall in cases 
2007 Finlay Institute, 
Cuba41 
Leptospirosis Nosode + GE 2.2 million+ Significantly fewer cases 
2008 Finlay Institute, Cuba Leptospirosis Nosode + GE 2.2 million+ Significantly fewer cases 
2009 Finlay Institute, Cuba Swine Flu Nosode + GE 9.8 million+ No cases recorded 
2011 Lyrio42 Influenza Nosode 600+ Active group 1/3 of  
cases in placebo group 
2012 Finlay Institute, Cuba Dengue Fever Nosode + GE   
 
These few examples indicate the range of evidence available from well-constructed and 
rigorous HP interventions using both GE remedies and nosodes. There are more, and 
fortunately there is ongoing research in different countries to expand the evidentiary base of 
HP. 
 
 
Conclusions 
 
Teixeira's contribution was thorough, and contains valuable information. It is disappointing 
that the misunderstandings and errors noted above regarding the appropriate use of nosodes 
to prevent targeted infectious diseases lead Teixeira to attack the many thousands of  
homoeopathic practitioners internationally who use appropriate HP programs based on 
nosodes as transgressing ”the bioethical principles of beneficence and non-maleficence”. 
 
Nothing could be further from the truth. In fact evidence shows that appropriate 
homoeopathic immunisation using GE remedies and/or nosodes has the potential to prevent 
much suffering without any risk of possible short-term toxic damage or long-term energetic 
adverse effects. 
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STATE YOUR VIEW:   
TOWARDS AN INTERNATIONAL POSITION ON HOMOEOPROPHYLAXIS  
This is an invitation to participate in research that aims to quantify homeopathic 
practitioners’ attitudes towards, and use of homoeoprophylaxis (homeopathic immunisation).  
The following questionnaire will commence on 1/12/2013. 
Please log onto the following site no later than 28/2/2014:  
http://sitevm1.ballarat.edu.au/homeopathy_survey/index.php/215682/lang-en 
OR  www.homstudy.net/Practitioners/  
You will be asked for your consent to participate in the survey, and then asked for the 
following information which will take around 10 minutes to complete, or a little longer if you 
would like to make a statement to support your position: 
• Your name (optional): 
• Years in homeopathic practice: 
• Whether you a member of a professional homeopathic association, and if so which 
one? 
• Your country: 
• Should we attempt to prevent potentially serious infectious diseases?      
Yes/No 
• IF YES: If we should attempt to prevent potentially serious infectious diseases, which 
method should we use? Choose one of the following answers – (1) General protection 
only; (2) Disease-specific protection, or a combination of both methods: 
• IF (2): Which method of disease-specific protection should be used? 
Choose one of the following answers – (1) Vaccination; (2) Homoeoprophylaxis, or a 
combination of both methods: 
• IF (2): Is it appropriate to use both vaccination and homoeoprophylaxis?       
Yes/No 
• Use homoeoprophylaxis, but only during epidemics or acute outbreaks?      
Yes/No  
• Which position do you support (1-6)? (the 6 positions above will be listed in boxes, 
and you will be asked to move the boxes with your preferred position on top through 
to your least preferred position on the bottom):  
• You will be invited to make any additional comments you wish to support the position 
you have selected. Of course you may choose to make no further comment. 
• Have you, do you, or do you intend to, use some form of homoeoprophylaxis in your 
practice?          6 options will be offered for you to choose between. 
                                                                                                                                                                            
• Have you read Hahnemann’s Essay The Cure and Prevention of Scarlet Fever?     
Yes/No 
• Do you believe that homoeoprophylaxis is based on the Law/Principle of Similars?   
Yes/No 
• Finally you will be asked if you would like to be contacted with the results of the 
survey or if you wish to contribute further, and so provide your email address. Of 
course if you will remain anonymous if you prefer. 
 
 
